-
Most Recent
Biotech Stocks
Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
3 Promising Biotech Stocks for the Long-Term: August 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.
The 3 Best Healthcare Stocks to Buy in August 2024
These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.
Other industries you might be interested in
Recent Biotech Stocks Articles
Big Pharma Betting on Cancer-Drug Paydays
New revenue streams are needed to offset patent losses.
Biogen Shares Fetching Too High a Price
The financials are strong, but the stock is too expensive.
Lumber Liquidators Sinks as APAC Leaps
Midday trading led by takeover target APAC Customer Services (NASDAQ: APAC), Lumber Liquidators (NYSE: LL), and Hi-Tech Pharmacal (NASDAQ: HITK).
Resurgent Financial Stocks Offer Big Gains
Moody's report saying debit card changes could earn banks billions bolsters JP Morgan NYSE:JPM and Bank of America NYSE:BAC in early trading.
Regeneron Rally May Ride on Blindness Drug
A new revenue stream could mean a big boost for this stock.
4 Health Care Stocks That Are the Prescription for a Perfect Portfolio
For the long haul, the prospects for health care stocks are promising -- and not just as a defensive play. These four picks are just what the doctor ordered.
ObamaCare Court Test a Non-event for Health Stocks
Health insurance, pharmaceutical companies' gains show confidence that ObamaCare is all but a done deal.
Immucor, Ameron Buys Spur Midday Action
Midday Stock Volume Led By Immucor (NASDAQ: BLUD), Ameron (NYSE: AMN), Ryanair Holdings (NASDAQ: RYAAY), NetScout Systems (NASDAQ: NTCT).
Big Pharma Stocks Have Big Challenges Ahead
Tougher FDA approvals and expiring patents mean good times for Big Pharma could be fleeting, but a few stocks are worth striking at while the iron's hot.
7 Biotech Penny Stocks to Buy
Biotech stocks like Aastrom, Pluristem and iBio are penny powerhouses just waiting to explode.
Nike Stays Swift on Strong Earnings
Midday stock trading led by Nike (NYSE: NKE), Icagen (NASDAQ: ICGN, Accenture (NYSE: ACN) and Enbridge Energy Partners (NYSE: EEP).
Continucare Skyrockets on Buyout Bid
Midday trading action seen in Continucare (NYSE: CNU), Icagen (NASDAQ: ICGN), and EXCO Resources (NYSE: XCO).
Techs and European Debt Woes Weigh Down Dow
Tech stocks Oracle, Micron, Microsoft, Cisco bring Dow down in early trading, and Big Pharma's Pfizer off; consumer stocks up slightly.
Southern Union Soars on Buyout Bid
Midday trading led by Southern Union (NYSE: SUG), SuccessFactors (NASDAQ: SFSF), Aegerion Pharmaceuticals (NASDAQ: AEGR).
6 Biotech Penny Stocks to Buy
These stocks may just be the cure for an ailing portfolio.
Red Hat Rises and TreeHouse Trimmed
Midday trading action led by TreeHouse Foods (NYSE: THS), Bed Bath & Beyond (NASDAQL BBBY), Red Hat (NYSE: RHT).
Targacept Faces a Lonely Road
The company loses financial help on drug development.
2 Cancer Stocks to Approach With Caution
These companies are leading the pack in a new treatment for cancer, but investors should be wary.
